← Scroll for more →
Financial Statements — PHOE
Balance Sheet
(in millions USD)| Metric | Q4 2026 | Q2 2026 | Q4 2025 |
|---|---|---|---|
| Cash & Equivalents | 0.89 | 1.52 | 2.38 |
| Accounts Receivable | 4.62 | 5.18 | 1.63 |
| Total Current Assets | 6.10 | 8.32 | 5.02 |
| Property, Plant & Equipment | 0.01 | 0.05 | 0.01 |
| Total Non-current Assets | 1.23 | 0.37 | 0.35 |
| Total Assets | 7.32 | 8.70 | 5.37 |
| Accounts Payable | 0.57 | 1.01 | 1.35 |
| Total Current Liabilities | 1.12 | 1.19 | 2.24 |
| Total Non-current Liabilities | 0.05 | 0.02 | 0.02 |
| Total Liabilities | 1.16 | 1.20 | 2.26 |
| Retained Earnings | 1.53 | 2.93 | 2.73 |
| Total Stockholder Equity | 6.16 | 7.50 | 3.11 |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 |
|---|---|
| Total Revenue | 3.51 |
| Cost of Revenue | 2.77 |
| Gross Profit | 0.74 |
| Selling, General & Admin | 0.53 |
| Total Operating Expenses | 0.53 |
| Operating Income | 0.21 |
| Pretax Income | 0.21 |
| Tax Provision | 0.02 |
| Net Income | 0.20 |
| Basic EPS | 0.01 |
| Diluted EPS | 0.01 |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 |
|---|---|
| Operating Cash Flow | (5.02) |
| Capital Expenditures | 0.03 |
| Free Cash Flow* | (5.05) |
| Investing Cash Flow | (0.03) |
| Financing Cash Flow | 4.16 |
← Scroll for more columns →
* Derived from reported values